In:
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Vol. 46, No. 5 ( 2002-05), p. 1557-1560
Abstract:
The pharmacokinetics of piperacillin-tazobactam were investigated in eight anuric intensive care patients treated by continuous venovenous hemodialysis (CVVHD). The elimination half-life of piperacillin was 4.3 ± 1.2 h, and that of tazobactam was 5.6 ± 1.3 h. The contribution of CVVHD to the overall elimination was relevant ( 〉 25%) for both drugs.
Type of Medium:
Online Resource
ISSN:
0066-4804
,
1098-6596
DOI:
10.1128/AAC.46.5.1557-1560.2002
Language:
English
Publisher:
American Society for Microbiology
Publication Date:
2002
detail.hit.zdb_id:
1496156-8
SSG:
12
SSG:
15,3
Bookmarklink